Fresenius SE & Co. (OTCMKTS:FSNUY) Posts Earnings Results, Misses Expectations By $0.01 EPS

Fresenius SE & Co. (OTCMKTS:FSNUY) issued its earnings results on Wednesday. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%.

Fresenius SE & Co. Stock Performance

OTCMKTS FSNUY traded up $0.72 during trading hours on Wednesday, reaching $13.55. The stock had a trading volume of 8,263 shares, compared to its average volume of 152,603. Fresenius SE & Co. has a 52-week low of $10.33 and a 52-week high of $33.93. The stock has a fifty day moving average of $11.69 and a 200 day moving average of $12.77. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. The stock has a market cap of $30.54 billion, a P/E ratio of 18.07 and a beta of 0.61.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, July 21st. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.